Compliance Life Science Packaging Regulation 
XTalks
MAY 13, 2022
A container closure system consists of all the packaging components that contain and protect a pharmaceutical product. Container closure systems are highly regulated by health agencies. They provide specific guidance on packaging requirements for closed closure integrity (CCI) and general integrity testing.
XTalks
JULY 5, 2022
Employee retention and motivation is a challenge that all life science companies face. A corporate compliance training program is a part of many onboarding programs to ensure employees are up to date with the latest rules and regulations they must adhere to while working for the company. Employee Compensation and Rewards.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
JANUARY 4, 2022
Provided as a cloud or on-premise solution, PRISYM 360 is designed specifically to address the unique complexities of medical device, clinical trial and pharmaceutical labeling and packaging artwork. About PRISYM ID.
XTalks
MAY 31, 2024
Key Features of the EpiMonitor The EpiMonitor package includes two main components: the EmbracePlus wearable device and the EpiMonitor app, a dedicated smartphone application for seizure monitoring. The EpiMonitor earned US Food and Drug Administration (FDA) clearance for use in adults and children aged six and above.
pharmaphorum
OCTOBER 27, 2022
To help ensure compliance, it is advisable for companies to establish procedures to assess and verify IT security of social media and digital channels, and to review and monitor company activities, content, and materials. Why is guidance needed? What are the rules on Social Media Influencers and Digital Opinion Leaders? About the authors.
XTalks
MAY 9, 2023
As the demand for clinical trials continues to grow, so does the need for skilled professionals who can manage complex trial operations and ensure that studies are conducted in compliance with regulatory requirements. Ensuring compliance with applicable regulations, guidelines and ethical principles.
pharmaphorum
MAY 27, 2022
Once stakeholders are confident that technologies are adequately validated, selection based on scientific and ethical considerations can be presented to regulators in accordance with applicable legal and regulatory frameworks. As a Non-Clinical Assessor at MHRA he assessed non-clinical data packages for new and generic medicines.
Expert insights. Personalized for you.
98 
Let's personalize your content